Abbott Vascular
Enterprise
Employees
2,0008,200
Revenue
$122M$2,920M
Get your CRM ready forintelligent expansion
Stride continuously benchmarks your CRM against a validated view of the market, showing you what's missing, what's wrong, and what to fix next
Segmentation agent
Building| Company | Employees | Revenue | Segment |
|---|---|---|---|
Abbott Vascular | 2,0008,200 | $122M$2,920M | Enterprise |
MW Life Sciences | 1250 | $5M0 | Core |
Normec Group | 7506,000 | $45M$595M | Mid-Market |
OPED GmbH | 375900 | $14.5M$150M | Backlog |
MW Life Sciences
Core
Employees
1250
Revenue
$5M0
OPED GmbH
Backlog
Employees
375900
Revenue
$14.5M$150M
Built from growth experience at
The Problem
Your CRM looks complete. Until growth depends on it.
Most systems of record are built on stale, inherited, and unvalidated company data. They may look reliable, but break down when it matters most: routing, segmentation, pricing, territory planning, and market expansion.
Firmographic Benchmarks
Our human validated benchmarks assess the accuracy of firmographic data and AI-driven enrichment across the company attributes that drive GTM decisions.
83%
Stride
76%
Clay (Argon)
73%
GPT 5.4
63%
ZoomInfo
59%
Clay (Premium Data Providers)
More data. Less certainty.
Your team has more customer and company data than ever, but little way to know which inputs are accurate, reliable, or useful enough to guide revenue decisions.
More updates. Less impact.
AI can enrich records at scale, but most CRM updates still happen without a clear view of which changes will affect routing, segmentation, pricing, or customer experience. The result is expensive data work that adds fields, layers on vendors, and rarely changes the decisions that drive growth.
More tools. Less adoption.
Teams do not need another dashboard or source of truth. They need their existing CRM to reflect the market more accurately and guide better decisions inside the workflows they already use.
The Solution
Validate your data. Fix what matters. Act in your existing tools.
Stride helps GTM & strategy teams turn CRM uncertainty into ranked, deployable action. Footprint validates the market data behind your decisions. Agents identify the gaps that matter most. Integrations bring approved fixes into the tools your team already uses.
Benchmarking your CRM data
Accounts mapped
0 mapped
Confidence
0%
Agent mode
Pipeline Expansion
[00.0s]Preparing benchmark workflow...
Footprint
Validate your data.
A validated, benchmarked market layer with confidence ratings and human review, so teams can separate useful signals from unreliable inputs.
View FootprintAgents
Know what to fix first
Agents scan your CRM to find the missing, wrong, or outdated data most likely to affect routing, segmentation, pricing, expansion, and pipeline quality.
View AgentsIntegrations
Act in your existing tools
Approved updates and recommendations are surfaced inside your existing systems, so teams can act without learning yet another tool.
View IntegrationsWhy it matters
Better growth execution starts with a CRM that reflects the real market
When your CRM is incomplete, stale, or unvalidated, every downstream decision gets noisier: who owns an account, which segment it belongs in, how much potential it has, and where your team should focus. Stride improves the company and account data behind your company's GTM & strategic expansion, so teams can route, prioritise, plan, and expand with more confidence.
Route accounts with confidence
Reduce misrouting, ownership disputes, and territory conflict with cleaner firmographics, better entity structure, and a more accurate view of where companies operate.
Find the accounts your CRM is missing
Surface high-fit companies, subsidiaries, locations, and segments that are absent, misclassified, or under-covered in your CRM.
Prioritise the accounts that actually fit
Use validated company context, operating signals, and industry-aware logic to separate accounts that look similar from accounts that are more likely to matter.
Plan territories and expansion with better evidence
Ground TAM, territory, and market expansion decisions in a benchmarked view of the market, not stale CRM exports or generic enrichment.
Spend less on low-impact enrichment
Focus spend on the records, fields, and signals that change real GTM decisions, instead of paying to fill empty cells.